share_log

Xenon To Present Long-Term Azetukalner Data At AES 2024

Benzinga ·  Nov 25, 2024 08:33
  • Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOS
    • New pre-clinical data from the Company's Nav1.1 program
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment